Julie O'Neill, EVP Global Operations at ALEXION PHARMACEUTICALS INC (ALXN), sold 2,858 shares at $145.55 ($405K) on 2016-02-05, disclosed to the SEC on 2016-02-08.
Open-market sale of $405k ALXN by EVP Global Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.54 | 530 | $75K | 18.5% |
| 2 | $142.33 | 499 | $71K | 17.5% |
| 3 | $143.46 | 351 | $50K | 12.4% |
| 4 | $144.53 | 352 | $51K | 12.6% |
| 5 | $145.55 | 348 | $51K | 12.5% |
| 6 | $138.02 | 755 |
| $104K |
| 25.7% |
| 7 | $139.75 | 23 | $3K | 0.8% |
| Total | $141.83 avg | 2,858 | $405K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $557K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $248K | — | Filing → |
| ALXN | SELL | 2017-09-05 | $636K | — | Filing → |